NYMU Taipei/Part List
From 2007.igem.org
(Difference between revisions)
(→Part List) |
|||
(20 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
+ | <p><font size="4"> | ||
+ | [[NYMU_Taipei/ProjectDescription| Project Description]] / | ||
+ | [[NYMU_Taipei/Lab_Notes| Lab Notes]] / | ||
+ | [[NYMU_Taipei/Part_List| Part List]] / | ||
+ | [[NYMU_Taipei/Primer_List| Primer List]] | ||
+ | </font><br /><hr></p> | ||
+ | |||
+ | ==Part List== | ||
{| style="color:green;background-color:#ffffcc;" cellpadding="20" cellspacing="0" border="1" | {| style="color:green;background-color:#ffffcc;" cellpadding="20" cellspacing="0" border="1" | ||
!Series | !Series | ||
Line 5: | Line 13: | ||
!Description | !Description | ||
!part length | !part length | ||
- | ! | + | !vector (antibotics) |
+ | !Check | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_R0082 BBa_R0082] | |[http://partsregistry.org/Part:BBa_R0082 BBa_R0082] | ||
Line 13: | Line 22: | ||
|108 | |108 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |? | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_C0082 BBa_C0082] | |[http://partsregistry.org/Part:BBa_C0082 BBa_C0082] | ||
Line 27: | Line 37: | ||
|12 | |12 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |? | ||
|- | |- | ||
|AU43-C7 | |AU43-C7 | ||
Line 52: | Line 63: | ||
|D-term | |D-term | ||
|1,2,3 | |1,2,3 | ||
- | |Double | + | |Double transcription terminator |
|95 | |95 | ||
|pSB1AK3 | |pSB1AK3 | ||
+ | |OK | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_I14032 BBa_I14032] | |[http://partsregistry.org/Part:BBa_I14032 BBa_I14032] | ||
Line 67: | Line 79: | ||
|2 | |2 | ||
|OmpR binding sites | |OmpR binding sites | ||
+ | |65 | ||
| | | | ||
- | | | + | |? |
|- | |- | ||
|AV88-C6 | |AV88-C6 | ||
Line 94: | Line 107: | ||
|B0032.ECFP | |B0032.ECFP | ||
|16D, plate 1 | |16D, plate 1 | ||
- | | | + | |This part accepts POPS to produce ECFP under the medium RBS B0032 |
|742 | |742 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |OK | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_I15017 BBa_I15017] | |[http://partsregistry.org/Part:BBa_I15017 BBa_I15017] | ||
Line 104: | Line 118: | ||
|742 | |742 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |OK | ||
+ | |- | ||
+ | |[http://partsregistry.org/Part:BBa_E0840 BBa_E0840] | ||
+ | |B0030(RBS).E0040(GFP).B0015(D-term) | ||
+ | |16E, plate 1 | ||
+ | |gfp tri-part; strong rbs | ||
+ | |878 | ||
+ | |pSB1A2 | ||
+ | |OK | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_R0077 BBa_R0077] | |[http://partsregistry.org/Part:BBa_R0077 BBa_R0077] | ||
|pCinRHSL, RBS+ | |pCinRHSL, RBS+ | ||
|17L, Plate 1 | |17L, Plate 1 | ||
- | | | + | |CinR-HSL complex binds to this promoter and activates transcription. This part contains RBS. |
|231 | |231 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |OK | ||
|- | |- | ||
|- | |- | ||
Line 116: | Line 140: | ||
|pCinRHSL | |pCinRHSL | ||
|15D, Plate 1 | |15D, Plate 1 | ||
- | | | + | |CinR-HSL complex binds to this promoter and activates transcription. This part DOES NOT contain RBS. |
|225 | |225 | ||
|pSB1A2 | |pSB1A2 | ||
- | | | + | |? |
|- | |- | ||
|[http://partsregistry.org/Part:BBa_C0077 BBa_C0077] | |[http://partsregistry.org/Part:BBa_C0077 BBa_C0077] | ||
|CinR | |CinR | ||
|7G, Plate 2 | |7G, Plate 2 | ||
- | | | + | |cinR activator |
|762 | |762 | ||
|pSB2K3 | |pSB2K3 | ||
+ | |OK | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_C0076 BBa_C0076] | |[http://partsregistry.org/Part:BBa_C0076 BBa_C0076] | ||
|HSL | |HSL | ||
|7E, Plate 2 | |7E, Plate 2 | ||
- | | | + | |autoinducer |
|702 | |702 | ||
|pSB2K3 | |pSB2K3 | ||
+ | |OK | ||
|- | |- | ||
|} | |} | ||
- | + | ||
- | + | ==antibiotics keys== | |
- | ** K: [http://en.wikipedia.org/wiki/Kanamycin Kanamycin] | + | * A: [http://en.wikipedia.org/wiki/Ampicillin Ampicillin] |
- | + | ** refernece at OpenWetWare: http://openwetware.org/wiki/Ampicillin | |
+ | ** stock (100 mg/mL = 100 ug/uL) ampicillin | ||
+ | ** liquid culture (50 ug/mL = 250 ug/5mL) | ||
+ | ** 5mL liquid culture = 5 c.c. LB + 2.5uL stock ampicillin | ||
+ | * K: [http://en.wikipedia.org/wiki/Kanamycin Kanamycin] | ||
+ | * C: [http://en.wikipedia.org/wiki/Chloramphenicol Chloramphenicol] | ||
+ | ** 35 mg/mL | ||
+ | ** 20 mg/mL in Ethanol | ||
+ | ** we prepared 100mg in 5 mL and stored in -20 C |
Latest revision as of 09:08, 24 January 2008
Project Description /
Lab Notes /
Part List /
Primer List
Part List
Series | alias | Location | Description | part length | vector (antibotics) | Check |
---|---|---|---|---|---|---|
[http://partsregistry.org/Part:BBa_R0082 BBa_R0082] | pOmpC | 1 | Positively regulated, OmpR-controlled promoter | 108 | pSB1A2 | ? |
[http://partsregistry.org/Part:BBa_C0082 BBa_C0082] | tar-envZ | 1 | Receptor, tar-envZ | 1491 | pSB2K3 | |
[http://partsregistry.org/Part:BBa_B0034 BBa_B0034] | RBS | 1,2,3 | The Elowitz RBS (Ribosome binding site) is the definition of efficiency 1.0 | 12 | pSB1A2 | ? |
AU43-C7 | [http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=13528923 INS] | human insulin | 495 | C | ||
INS_A | 1 | alpha chain of human insulin | 63 | |||
INS_B | 1 | beta chain of human insulin | 90 | |||
[http://partsregistry.org/Part:BBa_B0014 BBa_B0014] | D-term | 1,2,3 | Double transcription terminator | 95 | pSB1AK3 | OK |
[http://partsregistry.org/Part:BBa_I14032 BBa_I14032] | pLacIQ | 2 | Constitutive Promoter, High Transcription | 37 | pSB2K3 | |
OmpRBS | 2 | OmpR binding sites | 65 | ? | ||
AV88-C6 | [http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=27371195 IDE] | 2 | insulin degradation enzyme of mouse | 3445 | A | |
AU61-F6 | [http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=33879043 IGFBP3] | 2 | Insulin-like growth factor binding protein 3 of human | 2488 | C | |
AU50-C7 | [http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=38114635 IGFBP7] | 2 | Insulin-like growth factor binding protein 7 of human | 1155 | C | |
[http://partsregistry.org/Part:BBa_I15016 BBa_I15016] | B0032.ECFP | 16D, plate 1 | This part accepts POPS to produce ECFP under the medium RBS B0032 | 742 | pSB1A2 | OK |
[http://partsregistry.org/Part:BBa_I15017 BBa_I15017] | B0032.EYFP | 16F, plate 1 | This part accepts POPS to generate EYFP under the medium strength RBS B0032 | 742 | pSB1A2 | OK |
[http://partsregistry.org/Part:BBa_E0840 BBa_E0840] | B0030(RBS).E0040(GFP).B0015(D-term) | 16E, plate 1 | gfp tri-part; strong rbs | 878 | pSB1A2 | OK |
[http://partsregistry.org/Part:BBa_R0077 BBa_R0077] | pCinRHSL, RBS+ | 17L, Plate 1 | CinR-HSL complex binds to this promoter and activates transcription. This part contains RBS. | 231 | pSB1A2 | OK |
[http://partsregistry.org/Part:BBa_R0078 BBa_R0078] | pCinRHSL | 15D, Plate 1 | CinR-HSL complex binds to this promoter and activates transcription. This part DOES NOT contain RBS. | 225 | pSB1A2 | ? |
[http://partsregistry.org/Part:BBa_C0077 BBa_C0077] | CinR | 7G, Plate 2 | cinR activator | 762 | pSB2K3 | OK |
[http://partsregistry.org/Part:BBa_C0076 BBa_C0076] | HSL | 7E, Plate 2 | autoinducer | 702 | pSB2K3 | OK |
antibiotics keys
- A: [http://en.wikipedia.org/wiki/Ampicillin Ampicillin]
- refernece at OpenWetWare: http://openwetware.org/wiki/Ampicillin
- stock (100 mg/mL = 100 ug/uL) ampicillin
- liquid culture (50 ug/mL = 250 ug/5mL)
- 5mL liquid culture = 5 c.c. LB + 2.5uL stock ampicillin
- K: [http://en.wikipedia.org/wiki/Kanamycin Kanamycin]
- C: [http://en.wikipedia.org/wiki/Chloramphenicol Chloramphenicol]
- 35 mg/mL
- 20 mg/mL in Ethanol
- we prepared 100mg in 5 mL and stored in -20 C